MENU
NKTR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Nektar Therapeutics (NKTR) Ownership - Who owns Nektar Therapeutics?
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
137
Web
https://www.nektar.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
368.24M
P/E Ratio
N/A
Total Cash
218.63M
Projected Growth
N/A
Total Debt
100.34M
Revenue
87.25M
Risk (Beta)
0.64
Dividend Yield
N/A
Total Cash/Share
17.62
Total Debt/Equity
N/A
Revenue/Share
6.24 USD as % of share price
Fundamentals
NKTR
Capitalization
368M
P/E Ratio
N/A
Risk (Beta)
0.64
Dividend Yield
N/A
Total Cash
219M
Total Cash/Share
17.62
Total Debt
100M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.24%
Revenue
87.2M
ROE
N/A
Book Value
13.7M
P/B Ratio
26.81
Cash Flow
N/A
Earnings
-9.45
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
19K
Current Ratio
3.24
Current Revenue Per Employee
171475.40
Dividends Per Share - Security
N/A
EBITDA
-97.97M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-40.79
Shares Held By Institutions
102M
Shares Outstanding - Current
12.4M
Total Liabilities
243M
Total Volume MTD
N/A
Value
-1
Gain YTD
108.746
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of inhalation drug delivery systems
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
137
Web
https://www.nektar.com